Safety &Efficacy of CF101 to Subjects With Uveitis
Status:
Withdrawn
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, randomized, double-masked, placebo-controlled study subjects with active,
sight-threatening, noninfectious intermediate or posterior uveitis.